Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Lantern Pharma Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- +3 vs. Q3 2023
- Shares held
- 1.16M
- +1.55K (+0.1%) vs. Q3 2023
- Total value
- $4.94M
- +$1.01M (+25.7%) vs. Q3 2023
- New holders
- 3
- 6 more added
- Sold out
- 0
- 13 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LTRN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $12.0M |
| Q1 2026 | 33 | $2.87M |
| Q4 2025 | 33 | $6.91M |
| Q3 2025 | 30 | $9.89M |
| Q2 2025 | 35 | $7.11M |
| Q1 2025 | 32 | $8.62M |
| Q4 2024 | 32 | $8.00M |
| Q3 2024 | 31 | $4.90M |
| Q2 2024 | 39 | $6.01M |
| Q1 2024 | 34 | $9.75M |
| Q4 2023 | 30 | $4.94M |
| Q3 2023 | 27 | $3.93M |
| Q2 2023 | 25 | $6.50M |
| Q1 2023 | 21 | $5.23M |
| Q4 2022 | 23 | $5.40M |
| Q3 2022 | 26 | $6.84M |
| Q2 2022 | 26 | $8.06M |
| Q1 2022 | 25 | $10.4M |
| Q4 2021 | 33 | $13.1M |
| Q3 2021 | 25 | $15.7M |
| Q2 2021 | 22 | $19.7M |
| Q1 2021 | 24 | $25.5M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Lantern Pharma Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 86 | $0 | 0.00% | −20−18.9% | Reduced |
| Qube Research & Technologies Ltd | 2 | $9 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 5 | $21 | 0.00% | +5 | New |
| JPMorgan Chase & Co | 13 | $56 | 0.00% | +4+44.4% | Added |
| Allworth Financial LP | 100 | $428 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 200 | $856 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 228 | $975 | 0.00% | 00.0% | Unchanged |
| Wolff Wiese Magana LLC | 600 | $2.57K | 0.00% | −1,600−72.7% | Reduced |
| Morgan Stanley | 600 | $2.57K | 0.00% | +600 | New |
| Tower Research Capital LLC (TRC) | 1,164 | $4.98K | 0.00% | −693−37.3% | Reduced |
| Wells Fargo & Company | 4,495 | $19.2K | 0.00% | +3+0.1% | Added |
| Dimensional Fund Advisors LP | 11,828 | $50.6K | 0.00% | +11,828 | New |
| Sigma Planning Corp | 11,875 | $50.8K | 0.00% | −6,250−34.5% | Reduced |
| Northern Trust Corp | 12,593 | $53.9K | 0.00% | 00.0% | Unchanged |
| Meridian Wealth Management, LLC | 19,660 | $84.1K | 0.01% | +3,000+18.0% | Added |
| BlackRock Inc. | 19,962 | $85.4K | 0.00% | −186−0.9% | Reduced |
| Citadel Advisors LLC | 24,858 | $106.4K | 0.00% | −5,774−18.8% | Reduced |
| UBS Group AG | 25,958 | $111.1K | 0.00% | −1,042−3.9% | Reduced |
| Bank of New York Mellon Corp | 26,481 | $113.3K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 27,752 | $118.8K | 0.00% | 00.0% | Unchanged |
| Pathway Financial Advisors LLC | 28,501 | $122.0K | 0.04% | −4,270−13.0% | Reduced |
| Horizon Kinetics Asset Management LLC | 28,791 | $123.2K | 0.00% | −1,209−4.0% | Reduced |
| Redmond Asset Management, LLC | 40,662 | $174.0K | 0.06% | −5,844−12.6% | Reduced |
| Renaissance Technologies LLC | 43,800 | $187.0K | 0.00% | +5,700+15.0% | Added |
| Commonwealth Equity Services, LLC | 58,848 | $252.0K | 0.00% | +43,480+282.9% | Added |
| Carlson Capital L P | 60,000 | $256.8K | 0.02% | −35,000−36.8% | Reduced |
| CM Management, LLC | 80,000 | $342.4K | 0.28% | +5,000+6.7% | Added |
| Geode Capital Management, LLC | 95,036 | $406.8K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 165,972 | $710.4K | 0.01% | −4,059−2.4% | Reduced |
| Vanguard Group Inc | 365,334 | $1.56M | 0.00% | −2,120−0.6% | Reduced |